CLEVER HANDELN

Richten Sie Börsennews.de als Startseite ein

Hier klicken

DAINIPPON SUMITOMO PHARMA Aktie

DAINIPP.SUMITOMO PHARMA CO.LTD REGISTERED SHARES O.N.

ISIN: JP3495000006

 | 

WKN: 858257

 | 

Symbol: DPM

 | 

Land: Japan


7,63 EUR 1,6931%

Die besten Rohstoffaktien der Welt

Zu Ihrem Onlinebroker

kaufen verkaufen
Deutsche Bank DAB bank AG OnVista Bank ViTrade 1822direkt flatex S Broker comdirect ING DiBa Sino Cortal Consors maxblue TARGOBANK alle vergleichen
Deutsche Bank DAB bank AG OnVista Bank ViTrade 1822direkt flatex S Broker comdirect ING DiBa Sino Cortal Consors maxblue TARGOBANK alle vergleichen

DAINIPPON SUMITOMO PHARMA Aktienkurs

: 25.05. ( 15 Min. verzögert)
7,63 €
Letzter Kurs
 1,69%
Veränderung
 7,50 €
Vortag
 7,55 €
Eröffnungskurs

Alle News aus dem Web zur DAINIPPON SUMITOMO PHARMA Aktie

  • 25.05.

    Market & Company News: Updates on EBAY, JCP, BKS, DELL, MSFT, GMCR

    US generic drug maker Mylan Inc. (NASDAQ:MYL) settled a patent infringement suit with Sunovion Pharmaceuticals, a unit of Japanese drug maker Dainippon Sumitomo Pharma Co., Ltd. (TYO:4506), over the bronchitis and emphysema drug Brovana.

  • 25.05.

    What you need to know before markets open

    US generic drug maker Mylan Inc settled a patent infringement suit with Sunovion Pharmaceuticals Inc, a unit of Dainippon Sumitomo Pharma Co, related to the Japanese drugmaker's bronchitis medicine Brovana. PayPal has made deals with 15 retailers ...

  • 25.05.

    Stock index futures signal higher open

    O) settled a patent infringement suit with Sunovion Pharmaceuticals Inc, a unit of Dainippon Sumitomo Pharma Co (4506.T), related to the Japanese drugmaker's bronchitis medicine Brovana. PayPal has made deals with 15 retailers including Toys R...

  • 25.05.

    Mylan settles patent suit over Sunovion's lung drug

    US generic drug maker Mylan Inc settled a patent infringement suit with Sunovion Pharmaceuticals Inc, a unit of Dainippon Sumitomo Pharma Co, related to the Japanese drugmaker's bronchitis medicine Brovana. Mylan said Sunovion has acknowledged that its ...

  • 25.05.

    Mylan settles patent suit over Sunovion's lung drug

    May 24 (Reuters) - US generic drug maker Mylan Inc settled a patent infringement suit with Sunovion Pharmaceuticals Inc, a unit of Dainippon Sumitomo Pharma Co, related to the Japanese drugmaker's bronchitis medicine Brovana.